Vardenafil Completed Phase 1 Trials for Genetic Polymorphic CYP3A5 / Pharmacokinetics of Three PDE5Is / Healthy Volunteers Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT00767598The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects